Cargando…

Hearing loss and intellectual outcome in children treated for embryonal brain tumors: Implications for young children treated with radiation sparing approaches

PURPOSE: We investigate the impact of severe sensorineural hearing loss (SNHL) and for the first time evaluate the effect of unilateral versus bilateral SNHL on intellectual outcome in a cohort of children with embryonal brain tumors treated with and without radiation. METHODS: Data were from 94 chi...

Descripción completa

Detalles Bibliográficos
Autores principales: Moxon‐Emre, Iska, Dahl, Christine, Ramaswamy, Vijay, Bartels, Ute, Tabori, Uri, Huang, Annie, Cushing, Sharon L., Papaioannou, Vicky, Laperriere, Normand, Bouffet, Eric, Mabbott, Donald J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525144/
https://www.ncbi.nlm.nih.gov/pubmed/34480430
http://dx.doi.org/10.1002/cam4.4245
_version_ 1784585634433728512
author Moxon‐Emre, Iska
Dahl, Christine
Ramaswamy, Vijay
Bartels, Ute
Tabori, Uri
Huang, Annie
Cushing, Sharon L.
Papaioannou, Vicky
Laperriere, Normand
Bouffet, Eric
Mabbott, Donald J.
author_facet Moxon‐Emre, Iska
Dahl, Christine
Ramaswamy, Vijay
Bartels, Ute
Tabori, Uri
Huang, Annie
Cushing, Sharon L.
Papaioannou, Vicky
Laperriere, Normand
Bouffet, Eric
Mabbott, Donald J.
author_sort Moxon‐Emre, Iska
collection PubMed
description PURPOSE: We investigate the impact of severe sensorineural hearing loss (SNHL) and for the first time evaluate the effect of unilateral versus bilateral SNHL on intellectual outcome in a cohort of children with embryonal brain tumors treated with and without radiation. METHODS: Data were from 94 childhood survivors of posterior fossa (PF) embryonal brain tumors who were treated with either: (1) chemotherapy alone (n = 16, 7.11 [3.41] years, 11M/5F), (2) standard‐dose craniospinal irradiation (CSI) and/or large boost volumes (n = 44, 13.05 [3.26] years, 29M/15F), or (3) reduced‐dose CSI with a boost restricted to the tumor bed (n = 34, 11.07 [3.80] years, 19M/15F). We compared intellectual outcome between children who: (1) did and did not develop SNHL and (2) developed unilateral versus bilateral SNHL. A Chang grade of ≥2b that required the use of a hearing aid was considered severe SNHL. Comparisons were made overall and within each treatment group separately. RESULTS: Patients who developed SNHL had lower full scale IQ (p = 0.007), verbal comprehension (p = 0.003), and working memory (p = 0.02) than patients without SNHL. No differences were observed between patients who had unilateral versus bilateral SNHL (all p > 0.05). Patients treated with chemotherapy alone who developed SNHL had lower mean working memory (p = 0.03) than patients who did not develop SNHL. Among patients treated with CSI, no IQ indices differed between those with and without SNHL (all p > 0.05). CONCLUSIONS: Children treated for embryonal brain tumors who develop severe SNHL have lower intellectual outcome than patients with preserved hearing: this association is especially profound in young children treated with radiation sparing approaches. We also demonstrate that intellectual outcome is similarly impaired in patients who develop unilateral versus bilateral SNHL. These findings suggest that early intervention to preserve hearing is critical.
format Online
Article
Text
id pubmed-8525144
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-85251442021-10-26 Hearing loss and intellectual outcome in children treated for embryonal brain tumors: Implications for young children treated with radiation sparing approaches Moxon‐Emre, Iska Dahl, Christine Ramaswamy, Vijay Bartels, Ute Tabori, Uri Huang, Annie Cushing, Sharon L. Papaioannou, Vicky Laperriere, Normand Bouffet, Eric Mabbott, Donald J. Cancer Med Clinical Cancer Researcher PURPOSE: We investigate the impact of severe sensorineural hearing loss (SNHL) and for the first time evaluate the effect of unilateral versus bilateral SNHL on intellectual outcome in a cohort of children with embryonal brain tumors treated with and without radiation. METHODS: Data were from 94 childhood survivors of posterior fossa (PF) embryonal brain tumors who were treated with either: (1) chemotherapy alone (n = 16, 7.11 [3.41] years, 11M/5F), (2) standard‐dose craniospinal irradiation (CSI) and/or large boost volumes (n = 44, 13.05 [3.26] years, 29M/15F), or (3) reduced‐dose CSI with a boost restricted to the tumor bed (n = 34, 11.07 [3.80] years, 19M/15F). We compared intellectual outcome between children who: (1) did and did not develop SNHL and (2) developed unilateral versus bilateral SNHL. A Chang grade of ≥2b that required the use of a hearing aid was considered severe SNHL. Comparisons were made overall and within each treatment group separately. RESULTS: Patients who developed SNHL had lower full scale IQ (p = 0.007), verbal comprehension (p = 0.003), and working memory (p = 0.02) than patients without SNHL. No differences were observed between patients who had unilateral versus bilateral SNHL (all p > 0.05). Patients treated with chemotherapy alone who developed SNHL had lower mean working memory (p = 0.03) than patients who did not develop SNHL. Among patients treated with CSI, no IQ indices differed between those with and without SNHL (all p > 0.05). CONCLUSIONS: Children treated for embryonal brain tumors who develop severe SNHL have lower intellectual outcome than patients with preserved hearing: this association is especially profound in young children treated with radiation sparing approaches. We also demonstrate that intellectual outcome is similarly impaired in patients who develop unilateral versus bilateral SNHL. These findings suggest that early intervention to preserve hearing is critical. John Wiley and Sons Inc. 2021-09-04 /pmc/articles/PMC8525144/ /pubmed/34480430 http://dx.doi.org/10.1002/cam4.4245 Text en © 2021 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Cancer Researcher
Moxon‐Emre, Iska
Dahl, Christine
Ramaswamy, Vijay
Bartels, Ute
Tabori, Uri
Huang, Annie
Cushing, Sharon L.
Papaioannou, Vicky
Laperriere, Normand
Bouffet, Eric
Mabbott, Donald J.
Hearing loss and intellectual outcome in children treated for embryonal brain tumors: Implications for young children treated with radiation sparing approaches
title Hearing loss and intellectual outcome in children treated for embryonal brain tumors: Implications for young children treated with radiation sparing approaches
title_full Hearing loss and intellectual outcome in children treated for embryonal brain tumors: Implications for young children treated with radiation sparing approaches
title_fullStr Hearing loss and intellectual outcome in children treated for embryonal brain tumors: Implications for young children treated with radiation sparing approaches
title_full_unstemmed Hearing loss and intellectual outcome in children treated for embryonal brain tumors: Implications for young children treated with radiation sparing approaches
title_short Hearing loss and intellectual outcome in children treated for embryonal brain tumors: Implications for young children treated with radiation sparing approaches
title_sort hearing loss and intellectual outcome in children treated for embryonal brain tumors: implications for young children treated with radiation sparing approaches
topic Clinical Cancer Researcher
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525144/
https://www.ncbi.nlm.nih.gov/pubmed/34480430
http://dx.doi.org/10.1002/cam4.4245
work_keys_str_mv AT moxonemreiska hearinglossandintellectualoutcomeinchildrentreatedforembryonalbraintumorsimplicationsforyoungchildrentreatedwithradiationsparingapproaches
AT dahlchristine hearinglossandintellectualoutcomeinchildrentreatedforembryonalbraintumorsimplicationsforyoungchildrentreatedwithradiationsparingapproaches
AT ramaswamyvijay hearinglossandintellectualoutcomeinchildrentreatedforembryonalbraintumorsimplicationsforyoungchildrentreatedwithradiationsparingapproaches
AT bartelsute hearinglossandintellectualoutcomeinchildrentreatedforembryonalbraintumorsimplicationsforyoungchildrentreatedwithradiationsparingapproaches
AT taboriuri hearinglossandintellectualoutcomeinchildrentreatedforembryonalbraintumorsimplicationsforyoungchildrentreatedwithradiationsparingapproaches
AT huangannie hearinglossandintellectualoutcomeinchildrentreatedforembryonalbraintumorsimplicationsforyoungchildrentreatedwithradiationsparingapproaches
AT cushingsharonl hearinglossandintellectualoutcomeinchildrentreatedforembryonalbraintumorsimplicationsforyoungchildrentreatedwithradiationsparingapproaches
AT papaioannouvicky hearinglossandintellectualoutcomeinchildrentreatedforembryonalbraintumorsimplicationsforyoungchildrentreatedwithradiationsparingapproaches
AT laperrierenormand hearinglossandintellectualoutcomeinchildrentreatedforembryonalbraintumorsimplicationsforyoungchildrentreatedwithradiationsparingapproaches
AT bouffeteric hearinglossandintellectualoutcomeinchildrentreatedforembryonalbraintumorsimplicationsforyoungchildrentreatedwithradiationsparingapproaches
AT mabbottdonaldj hearinglossandintellectualoutcomeinchildrentreatedforembryonalbraintumorsimplicationsforyoungchildrentreatedwithradiationsparingapproaches